Form D · Other Health Care

BIOWAVE CORP

Norwalk, CT · CIK 0001144161

Offering snapshot reported Dec 6, 2019 · SEC filing

Reported sold: $1.33M
Investors reported: 3
Minimum accepted: $0
First sale: Dec 7, 2018

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$1,000,000 → $1,329,449
Reported investors1 → 3

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 6, 2019	Amendment	$1,329,449	$329,449vs Dec 7, 2018	3	SEC filing
Dec 7, 2018	Initial	$1,000,000	No comparison	1	SEC filing
Jan 29, 2016	Initial	$749,429	No comparison	1	SEC filing
Aug 19, 2008	Paper	Not reported	No comparison	Not reported	SEC filing
May 30, 2007	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-327446

Additional shares of Series E Convertible Preferred Stock will be sold from time to time.

Source: Form D, filed Dec 6, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Robert Adler	Director
David Kratovil	Director, Executive
Bruce Lev	Director
Lance Lundberg	Director
L. Charles (Duke) Meythaler	Director
Bradford Siff	Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:

16 Knight St
Norwalk, CT, 06851